CNS adverse events associated with antimalarial agents. Fact or fiction?
about
The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitroAdverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?Effect of sample size and P-value filtering techniques on the detection of transcriptional changes induced in rat neuroblastoma (NG108) cells by mefloquinePrimaquine radical cure of Plasmodium vivax: a critical review of the literatureSevere falciparum malaria. World Health Organization, Communicable Diseases ClusterMefloquine damage vestibular hair cells in organotypic cultures.Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.Mefloquine for malaria chemoprophylaxis 1992-1998: a review.A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia.Thiamin supplementation does not reduce the frequency of adverse events after anti-malarial therapy among patients with falciparum malaria in southern Laos.Antimalarial activities of new pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives.Mefloquine induces dose-related neurological effects in a rat model.Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice.The antimalarial potential of 4-quinolinecarbinolamines may be limited due to neurotoxicity and cross-resistance in mefloquine-resistant Plasmodium falciparum strainsSafety evaluation of the drugs available to prevent malaria.Utility of alkylaminoquinolinyl methanols as new antimalarial drugs.A small-fish model for behavioral-toxicological screening of new antimalarial drugs: a comparison between erythro- and threo-mefloquine.Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patientsMefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin.Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial.Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trialAssessment of safety of the major antimalarial drugs.Resistant Malaria : Current Concepts and Therapeutic StrategiesInvestigation of the in vitro gender-specific partitioning of mefloquine in malarial infected red blood cells and plasmaThe neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.Neurotoxic mode of action of artemisinin.Possible role of heme oxygenase-1 and prostaglandins in the pathogenesis of cerebral malaria: heme oxygenase-1 induction by prostaglandin D(2) and metabolite by a human astrocyte cell line.Chloroquine-induced bilateral anterior shoulder dislocation: a unique aetiology for a rare clinical problem.Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection.Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study.Concise synthesis and antimalarial activity of all four mefloquine stereoisomers using a highly enantioselective catalytic borylative alkene isomerization.Possible neuroleptic malignant syndrome associated with olanzapine.Childhood mefloquine-induced mania and psychosis: a case report.Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate.Mefloquine in infants and young children.Mefloquine pharmacokinetics in healthy subjects and in peptic ulcer patients after cimetidine administration.Mefloquine for preventing malaria in pregnant women.A new approach for neurological evaluation of infants in resource-poor settings.Concise Synthesis and Antimalarial Activity of All Four Mefloquine Stereoisomers Using a Highly Enantioselective Catalytic Borylative Alkene Isomerization
P2860
Q24800302-4A0BF8BE-FF20-43B4-BC32-1B6BCA8C1576Q24806081-97746A2C-4181-4DF9-A958-C42D7EE30725Q24806854-14C74ACD-C742-4BFF-9B04-9682BD92B0D6Q27027939-CD8573DD-929A-4342-A332-123F0168F488Q29614923-DBEE37C5-2D60-4A36-A826-875F9FCA4864Q30466244-DC348E0E-F6DD-4DF2-91CE-A7F3E73768E5Q30478626-E422D130-4578-4F35-84B1-AFAA91E65EC4Q33669693-F9A48CA2-77D2-402F-99F9-2BBA5EF2FC3EQ33693580-3DCB3156-D3B5-4564-BBA3-9EFF7A492CB8Q33929242-AB574CBF-B33E-45AE-BF9F-44DBDF8F3ACEQ34228300-C53342A7-A596-437A-8481-C18A988007E1Q34509705-D5B7C3FC-9693-499F-9DDB-1C0A754AF65BQ35047028-9832D0C8-4669-45FB-992F-7D2E3FBC212FQ35124519-A16648E8-A77C-499C-A7C4-9D549844E34AQ35194527-8AD23019-4230-4C0A-A6C0-64FED9C88956Q35215427-432BD30A-4840-46D1-A2C4-8EF000459C82Q35606501-F9CAC115-9A52-46EB-BEC2-65F626A58BA1Q36278433-C2E1A957-7E18-467F-9BC0-C4C8DF496F85Q36424992-9041A6A9-1718-4D67-B500-B3AE01EAA1C3Q36561097-92184D18-2338-4FF1-A1DA-D82EEDAFB4FDQ36580228-6986E9CC-0A5B-4B50-BE1B-36BB13DBCFB2Q36945007-F6443D6C-C6C6-458E-A94D-4865698B0F24Q37048131-B1F3BAAE-E6BB-4D21-9F98-031B295F1332Q37225808-76FC271F-CB8F-4B53-882F-BB15D2434633Q37346189-0DBC4A66-AAF3-4747-ADA4-7C44BBF1260DQ39653002-96FBCC5F-AC5E-4ED5-81C1-C0D0FD63BB1CQ39723741-0F80DBAA-74D1-4A44-BEA0-A8DDFABA4B71Q39896650-B01CEEDE-95BD-4886-99FD-FA73F14E05C6Q41912660-8B304CBC-F6FB-468F-BC67-61DC739B542FQ41926882-7715931D-EFBB-404C-B286-0AB6FC47BC44Q42710437-90460151-8EB4-4054-A125-91A1217995CBQ43504024-0DBC2ABE-B756-4C62-A604-F4809AE11074Q46084342-5C2523EF-6489-455D-A4FF-2160117F45D0Q47979514-9279C1A1-D83C-41B8-9D54-30D70B552BA4Q48035075-B9284909-FE2C-45B3-848F-F5CE09AC1807Q50651490-70894F29-F81A-4045-B191-E102E6771878Q51737259-36771AC3-AB8B-46C3-9EDA-5A3B7D7B4CBAQ52110176-61213D51-7E91-4118-B7DF-96F1BB5D8BB5Q56656018-4257B215-5E4E-4247-93D0-89E4A8CC5B48
P2860
CNS adverse events associated with antimalarial agents. Fact or fiction?
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
CNS adverse events associated with antimalarial agents. Fact or fiction?
@ast
CNS adverse events associated with antimalarial agents. Fact or fiction?
@en
CNS adverse events associated with antimalarial agents. Fact or fiction?
@nl
type
label
CNS adverse events associated with antimalarial agents. Fact or fiction?
@ast
CNS adverse events associated with antimalarial agents. Fact or fiction?
@en
CNS adverse events associated with antimalarial agents. Fact or fiction?
@nl
prefLabel
CNS adverse events associated with antimalarial agents. Fact or fiction?
@ast
CNS adverse events associated with antimalarial agents. Fact or fiction?
@en
CNS adverse events associated with antimalarial agents. Fact or fiction?
@nl
P1433
P1476
CNS adverse events associated with antimalarial agents. Fact or fiction?
@en
P2093
F O ter Kuile
P A Phillips-Howard
P304
P356
10.2165/00002018-199512060-00003
P577
1995-06-01T00:00:00Z
P5875
P6179
1049064881